Alzheimer’s Drug Market To Hit $13 Billion As FDA Approvals And Insurance Coverage Escalate

The global market for Alzheimer’s disease treatments is expected to rise past $13 billion by 2030 as new drugs shown to slow cognitive decline are launched following key U.S. Food and Drug Administration approvals.